Head/Neck and Endocrine Flashcards
Fossa of Rosemillar cancer type and virus
nonkeartinizing and undifferentiated cancer, EBV
Field cancerization implications
H/N cancer may have second cancer in aerodigstrive tract
Most important prognostic factor for H/N SCC
Stage at time of diagnosis
Treatment of early stage H/N SCC
surgery or radiation (depending on performance status)
Role for accelerated fraction radiation
Only without chemotherapy
Role for concomitant chemoradiation as front line
Locally advancement (stage III or IVA/B)
Chemo given with radiation for H/N SCC
Cisplatin or carboplatin
Combination chemotherapy for metastatic or unresectable H/N SCC surgery unable to tolerate radiation
Cisplatin+5-FU+cetuximab
Second line therapy for metastatic H/N SCC
Nivo/Pembro or cetuxiumabn
Treatment of salivary tumor
Resection
Orophayngeal cancer first line treatment
Chemoradiation with involvement of bilateral neck
Treatment of persistent disease after completion of chemoreadiation
Surgery
Chemo (if not surgical candidate)
Familial syndromes for MTC
MEN2A and MEN2B
Mutations in differentiated thyroid cancer
BRAF V600E
Indication for FNA in thyroid mass
Normal/high TSH or non-hyperfunctional nodule on radionucleotide scan
Management of negative FNA
Rebiopsy in 3+ months
Markers for MTC (2)
Calcitonin and CEA
Total thyroidectomy indications (3)
> 4cm differentiated
MTC
Anaplastic (may need neoadjuvant therapy)
Indications for RAI postthyroidectomy
Differentiated with extrathyroid extension
TSH suppression role
Differentiated only, stage II+
Monitoring after RAI
Tg, anti-Tg Ab
Treatment of metastatic differentiated thyroid
Sorafanib or lenvatininib
Treatment of metastatic MTC
Vandetanib or cabozantinib
Treatment of anaplastic thyroid cancer
EBRT with doxorubicin radiosensitizing
Systemic therapy for adrenocortical carcinoma
Platinum + etoposide + doxorubicin +mitotane
Radiographic findings of adrenocortical carcinoma
> 10 Hounsfield units
Delayed washout, irregular borders
Mutation associated with adrenocortical carcinoma
TP53
Cell of origin for pheochromocytoma
chromaffin cell of adrenal medulla
Genetic associations with pheochromocytoma (3)
MEN2A/2B
NF1
VHL
Biochemical testing for pheochromocytoma
Fractionated plasma free metanephrines
24 hour urine fractionated metanephrines
Preoperative care before pheo resection
alpha1 blockade (phenoxybenzamine)
Scan for pheochromocytoma
131I-MIBG scan
Metastatic pheochromocytoma chemo
cyclophosphamide, vincristine, dacarbazine
Lymphoepithelial carcinoma virus
EBV